Shares of Fresenius Medical Care AG & Co. KGaA (NYSE:FMS – Get Free Report) have received a consensus recommendation of “Hold” from the seven research firms that are presently covering the company, Marketbeat reports. Three research analysts have rated the stock with a sell rating, one has issued a hold rating, two have issued a buy rating and one has issued a strong buy rating on the company. The average twelve-month price objective among brokers that have covered the stock in the last year is $27.80. Get ...